| 000 | 01249 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250510214944.0 | ||
| 264 | 0 | _c19770425 | |
| 008 | 197704s 0 0 eng d | ||
| 022 | _a0095-1544 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKurz, J B | |
| 245 | 0 | 0 |
_aInhibition of G2 phase in unsynchronized HELA cells: synergism between adenosine 3':5'-monophosphate analogues and phosphodiesterase inhibitors. _h[electronic resource] |
| 260 |
_bJournal of cyclic nucleotide research _c |
||
| 300 |
_a405-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBucladesine _xpharmacology |
| 650 | 0 | 4 |
_aCaffeine _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCyclic AMP _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCyclic GMP _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGuanine Nucleotides _xpharmacology |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aPhosphodiesterase Inhibitors |
| 650 | 0 | 4 |
_aTheophylline _xpharmacology |
| 650 | 0 | 4 |
_aXanthines _xpharmacology |
| 700 | 1 | _aFriedman, D L | |
| 773 | 0 |
_tJournal of cyclic nucleotide research _gvol. 2 _gno. 6 _gp. 405-15 |
|
| 999 |
_c186380 _d186380 |
||